Your browser doesn't support javascript.
loading
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Soria-Juan, Barbara; Garcia-Arranz, Mariano; Llanos Jiménez, Lucía; Aparicio, César; Gonzalez, Alejandro; Mahillo Fernandez, Ignacio; Riera Del Moral, Luis; Grochowicz, Lukasz; Andreu, Enrique J; Marin, Pedro; Castellanos, Gregorio; Moraleda, Jose Maria; García-Hernández, Ana Maria; Lozano, Francisco S; Sanchez-Guijo, Fermin; Villarón, Eva María; Parra, Miriam Lopez; Yañez, Rosa María; de la Cuesta Diaz, Antonio; Tejedo, Juan Rigoberto; Bedoya, Francisco J; Martin, Franz; Miralles, Manuel; Del Rio Sola, Lourdes; Fernández-Santos, María Eugenia; Ligero, José Manuel; Morant, Francisco; Hernández-Blasco, Luis; Andreu, Etelvina; Hmadcha, Abdelkrim; Garcia-Olmo, Damian; Soria, Bernat.
Afiliação
  • Soria-Juan B; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain.
  • Garcia-Arranz M; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain.
  • Llanos Jiménez L; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain. lucia.llanos@quironsalud.es.
  • Aparicio C; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain.
  • Gonzalez A; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain.
  • Mahillo Fernandez I; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain.
  • Riera Del Moral L; La Paz University Hospital, Madrid, Spain.
  • Grochowicz L; Navarra University Clinic, Pamplona, Navarra, Spain.
  • Andreu EJ; Navarra University Clinic, Pamplona, Navarra, Spain.
  • Marin P; Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Castellanos G; Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Moraleda JM; Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • García-Hernández AM; Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Lozano FS; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.
  • Sanchez-Guijo F; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.
  • Villarón EM; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.
  • Parra ML; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.
  • Yañez RM; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.
  • de la Cuesta Diaz A; Queen Victoria Eugenia-Cruz Roja Hospital, Sevilla, Spain.
  • Tejedo JR; University of Pablo de Olavide, Sevilla, Spain.
  • Bedoya FJ; University of Pablo de Olavide, Sevilla, Spain.
  • Martin F; Network Center for Research in Diabetes and Associated Metabolic Diseases (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas-CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • Miralles M; University of Pablo de Olavide, Sevilla, Spain.
  • Del Rio Sola L; La Fe University Hospital, Valencia, Spain.
  • Fernández-Santos ME; Valladolid Clinical University Hospital, Valladolid, Spain.
  • Ligero JM; Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain.
  • Morant F; Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain.
  • Hernández-Blasco L; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.
  • Andreu E; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.
  • Hmadcha A; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.
  • Garcia-Olmo D; University Miguel Hernández de Elche, Alicante, Spain.
  • Soria B; University of Pablo de Olavide, Sevilla, Spain.
Trials ; 22(1): 595, 2021 Sep 06.
Article em En | MEDLINE | ID: mdl-34488845
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Diabetes Mellitus Tipo 2 / Células-Tronco Mesenquimais / COVID-19 / Noma Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Diabetes Mellitus Tipo 2 / Células-Tronco Mesenquimais / COVID-19 / Noma Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article